- Weitere Titel
-
Checkpoint-Inhibitoren als Adjuvantien für virale Impfstoffe
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Dissertation, 2020
- Schlagwort
-
Viral vaccines
- Ereignis
-
Veröffentlichung
- (wo)
-
Erlangen
- (wer)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (wann)
-
2020
- Urheber
- Beteiligte Personen und Organisationen
-
Überla, Klaus
Eichler, Jutta
- URN
-
urn:nbn:de:bvb:29-opus4-149301
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:56 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Tannig, Pierre
- Überla, Klaus
- Eichler, Jutta
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Entstanden
- 2020
Ähnliche Objekte (12)
Deciphering immune signatures induced by viral vector vaccines against the Ebola virus
Process intensification and integration for the production of vaccines and viral vectors
Neurotoxicities associated with immune checkpoint inhibitor therapy
Checkpoint Inhibitoren zur Therapie des hepatozellulären Karzinoms
Neoantigens as potential vaccines in hepatocellular carcinoma
Characterization of Vaccinia virus MVA candidate vaccines mutated in viral genes modulating inflammasome activation
Veterinary vaccines
Conjugate vaccines
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
Immune checkpoint inhibitor induced neurocognitive deficits in patients
Stress protein complexed multidomain vaccines identify subdominant CD8 T-cells with enhanced anti-viral activity.
Reaction-Driven Fragment-Based Design of Viral Protease Inhibitors
Deciphering immune signatures induced by viral vector vaccines against the Ebola virus
Process intensification and integration for the production of vaccines and viral vectors
Neurotoxicities associated with immune checkpoint inhibitor therapy
Checkpoint Inhibitoren zur Therapie des hepatozellulären Karzinoms
Neoantigens as potential vaccines in hepatocellular carcinoma
Characterization of Vaccinia virus MVA candidate vaccines mutated in viral genes modulating inflammasome activation
Veterinary vaccines
Conjugate vaccines
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
Immune checkpoint inhibitor induced neurocognitive deficits in patients
Stress protein complexed multidomain vaccines identify subdominant CD8 T-cells with enhanced anti-viral activity.
Reaction-Driven Fragment-Based Design of Viral Protease Inhibitors
Deciphering immune signatures induced by viral vector vaccines against the Ebola virus
Process intensification and integration for the production of vaccines and viral vectors
Neurotoxicities associated with immune checkpoint inhibitor therapy
Checkpoint Inhibitoren zur Therapie des hepatozellulären Karzinoms
Neoantigens as potential vaccines in hepatocellular carcinoma
Characterization of Vaccinia virus MVA candidate vaccines mutated in viral genes modulating inflammasome activation
Veterinary vaccines
Conjugate vaccines
Progressive multifocal leukoencephalopathy treated by immune checkpoint inhibitors
Immune checkpoint inhibitor induced neurocognitive deficits in patients
Stress protein complexed multidomain vaccines identify subdominant CD8 T-cells with enhanced anti-viral activity.